Skip to main content

Advanced Nuclear Energy Licensing Cost-Share Grant Program

Agency: Idaho Field Office

Assistance Listings
  • 81.121 -- Nuclear Energy Research, Development and Demonstration

Open opportunityLast Updated: Oct 2, 2026

Important dates

  • Closing: November 30, 2026

Award details

  • Expected project funding: $50,000,000
  • Expected awards: 25

Award min.

$5,000

Award max.

$8,000,000

  • Funding opportunity number:DE-FOA-0003339
  • Cost sharing or matching requirement:Yes
  • Funding instrument type:
    • Grant
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Energy
  • Category Explanation:Not specified

History

  • Posted date: January 8, 2025
  • Archive date: Not specified
  • Version: 9

View version history on Grants.gov

U.S. Advanced Nuclear Energy Licensing Cost-Share Grant Program The application deadline for current review cycle, anticipated selection notification date for the current review cycle, and anticipated award date for current review cycle have changed. See date changes on page 6 of NOFO Part 1. Also, applications must now be submitted within the respective application period (July 1, 2026 – November 30, 2026). See date changes on page 24 of NOFO Part 1.

Eligibility

Business

  • Small businesses
  • For-profit organizations other than small businesses

Government

  • City or township governments
  • County governments
  • Federally recognized Native American tribal governments

Education

  • Private institutions of higher education
  • Public and state institutions of higher education

Nonprofit

  • Nonprofits non-higher education without 501(c)(3)

Additional information on eligibility

Not specified

Documents

File nameDescriptionLast updated
NOFO_DE-FOA-0003339_Part_2__Amendment_5_-_Final_1.pdf
Part 2
Apr 30, 2025 04:22 PM UTC
DE-FOA-0003339_Additional_QAs_-_4-28-25_1.pdf
Q and A
Apr 30, 2025 04:22 PM UTC
NOFO_DE-FOA-0003339_Part_1_Amendment_5_-_Final_2.pdf
Part 1
Apr 30, 2025 04:21 PM UTC
NOFO_DE-FOA-0003339_Part_2__Amendment_2_-_Final.pdf
NOFO DE-FOA-0003339 Part 2 , Amendment 2 - Final.pdf
Feb 3, 2025 08:10 PM UTC
NOFO_DE-FOA-0003339_Part_1_Amendment_2_-_Redline.pdf
NOFO DE-FOA-0003339 Part 1 Amendment 2 - Redline.pd
Feb 3, 2025 08:08 PM UTC
NOFO_DE-FOA-0003339_Part_1_Amendment_2_-_Final.pdf
NOFO DE-FOA-0003339 Part 1 Amendment 2 - Final.pdf
Feb 3, 2025 08:09 PM UTC
NOFO_DE-FOA-0003339_Part_2_Amendment_2_-_Redline.pdf
NOFO DE-FOA-0003339 Part 2 Amendment 2 - Redline.pdf
Feb 3, 2025 08:09 PM UTC
Questions_and_Answers_-_NOFO_-_DE-FOA-0003339_NRC_Licensing_Grants.pdf
Questions and Answers - NOFO - DE-FOA-0003339 NRC Licensing Grants
Feb 24, 2025 04:31 PM UTC
NOFO_DE-FOA-0003339_Part_2_Amendment_3_-_Redline.pdf
NOFO DE-FOA-0003339 Part 2 Amendment 3 - Redline
Feb 24, 2025 04:31 PM UTC
NOFO_DE-FOA-0003339_Part_2__Amendment_3_-_Final.pdf
NOFO DE-FOA-0003339 Part 2 , Amendment 3 - Final
Feb 24, 2025 04:30 PM UTC
NOFO_DE-FOA-0003339_Part_1_Amendment_2_-_Final.pdf
NOFO DE-FOA-0003339 Part 1 Amendment 2 - Final
Feb 14, 2025 08:10 PM UTC
NOFO_DE-FOA-0003339_Part_1_Amendment_3_-_Redline.pdf
NOFO DE-FOA-0003339 Part 1 Amendment 3 - Redline
Feb 24, 2025 04:30 PM UTC
NOFO_DE-FOA-0003339_Part_2__Amendment_2_-_Final.pdf
NOFO DE-FOA-0003339 Part 2 , Amendment 2 - Final
Feb 14, 2025 08:10 PM UTC
NOFO_DE-FOA-0003339_Part_1_Amendment_3_-_Final.pdf
NOFO DE-FOA-0003339 Part 1 Amendment 3 - Final
Feb 24, 2025 04:30 PM UTC
FundOpp_DE-FOA-0003339_Amd_000002.pdf
DE-FOA-0003339
Feb 14, 2025 08:11 PM UTC
NOFO_DE-FOA-0003339_Part_2_Amendment_2_-_Redline.pdf
NOFO DE-FOA-0003339 Part 2 Amendment 2 - Redline
Feb 14, 2025 08:11 PM UTC
NOFO_DE-FOA-0003339_Part_1_Amendment_2_-_Redline.pdf
NOFO DE-FOA-0003339 Part 1 Amendment 2 - Redline
Feb 14, 2025 08:10 PM UTC
FundOpp_DE-FOA-0003339_Amd_000003.pdf
DE-FOA-0003339
Feb 24, 2025 04:31 PM UTC
DE-FOA-0003339_Amendment_001_Summary.pdf
Summary
Jan 13, 2025 10:26 PM UTC
NOFO_DE-FOA-0003339_Part_1.pdf
Part 1
Jan 8, 2025 10:05 PM UTC
DE-FE-0003339_Notification_of_Funding_Opportunity_Part_1_Amendment_1_-_Redline.pdf
Part 1, Amendment 1 Redlined
Jan 13, 2025 10:27 PM UTC
NOFO_DE-FOA-0003339_Part_2.pdf
Part 2
Jan 8, 2025 10:05 PM UTC
DE-FE-0003339_Notification_of_Funding_Opportunity_Part_1_Amendment_1_-_Final.pdf
Part 1, Amendment 1
Jan 13, 2025 10:27 PM UTC
FundOpp_DE-FOA-0003339_Amd_000006.pdf
DE-FOA-0003339
Apr 2, 2026 07:08 PM UTC
NOFO_DE-FOA-0003339_Part_1_Amendment_6.pdf
NOFO DE-FOA-0003339 Part 1 Amendment 6
Apr 2, 2026 07:08 PM UTC
NOFO_DE-FOA-0003339_Part_2__Amendment_6.pdf
NOFO DE-FOA-0003339 Part 2 , Amendment 6
Apr 2, 2026 07:08 PM UTC
NOFO_DE-FOA-0003339_Part_1_Amendment_7.pdf
NOFO DE-FOA-0003339 Part 1 Amendment 7
Oct 2, 2026 03:26 PM UTC
NOFO_DE-FOA-0003339_Part_2__Amendment_7.pdf
NOFO DE-FOA-0003339 Part 2 , Amendment 7
Oct 2, 2026 03:26 PM UTC
FundOpp_DE-FOA-0003339_Amd_000007.pdf
DE-FOA-0003339
Oct 2, 2026 03:26 PM UTC

Agency contact information

Email: dutkevcd@id.doe.gov

Click to email contact

Charles D. Dutkevitch 208-526-4763 dutkevcd@id.doe.gov

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov